These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 21876563)

  • 41. Digital PCR Improves Mutation Analysis in Pancreas Fine Needle Aspiration Biopsy Specimens.
    Sho S; Court CM; Kim S; Braxton DR; Hou S; Muthusamy VR; Watson RR; Sedarat A; Tseng HR; Tomlinson JS
    PLoS One; 2017; 12(1):e0170897. PubMed ID: 28125707
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Foamy gland pancreatic ductal adenocarcinoma diagnosed on EUS-FNA: a histochemical, immunohistochemical, and molecular report.
    Bellevicine C; Malapelle U; Iaccarino A; Schettino P; Napolitano V; Zeppa P; Troncone G
    Diagn Cytopathol; 2013 Jan; 41(1):77-80. PubMed ID: 23008087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
    Mortensen MB
    Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of EGFR and KRAS mutation status from FNAs and core-needle biopsies of non-small cell lung cancer.
    Lozano MD; Labiano T; Echeveste J; Gurpide A; Martín-Algarra S; Zhang G; Sharma A; Palma JF
    Cancer Cytopathol; 2015 Apr; 123(4):230-6. PubMed ID: 25529460
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of EGFR and K-ras mutations in fixed and fresh specimens from transesophageal ultrasound-guided fine needle aspiration in non-small cell lung cancer patients.
    Ulivi P; Romagnoli M; Chiadini E; Casoni GL; Capelli L; Gurioli C; Zoli W; Saragoni L; Dubini A; Tesei A; Amadori D; Poletti V
    Int J Oncol; 2012 Jul; 41(1):147-52. PubMed ID: 22504767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variant Profiling of Candidate Genes in Pancreatic Ductal Adenocarcinoma.
    Huang J; Löhr JM; Nilsson M; Segersvärd R; Matsson H; Verbeke C; Heuchel R; Kere J; Iafrate AJ; Zheng Z; Ye W
    Clin Chem; 2015 Nov; 61(11):1408-16. PubMed ID: 26378065
    [TBL] [Abstract][Full Text] [Related]  

  • 47. K-ras mutation detected by peptide nucleic acid-clamping polymerase chain reaction, Ki-67, S100P, and SMAD4 expression can improve the diagnostic accuracy of inconclusive pancreatic EUS-FNB specimens.
    Kim BH; Kwon M; Lee D; Park SW; Shin E
    Pancreatology; 2024 Jun; 24(4):584-591. PubMed ID: 38693041
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endoscopic ultrasound fine needle aspirate DNA analysis to differentiate malignant and benign pancreatic masses.
    Khalid A; Nodit L; Zahid M; Bauer K; Brody D; Finkelstein SD; McGrath KM
    Am J Gastroenterol; 2006 Nov; 101(11):2493-500. PubMed ID: 17029619
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted Transcriptome and
    Lundy J; Gao H; Berry W; Masoumi-Moghoddam S; Jenkins BJ; Croagh D
    Clin Cancer Res; 2021 Nov; 27(21):5900-5911. PubMed ID: 34400416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictors of malignancy in patients with suspicious or indeterminate cytology on pancreatic endoscopic ultrasound-guided fine-needle aspiration: a multivariate model.
    Yang D; MoezArdalan K; Collins DP; Chauhan SS; Draganov PV; Forsmark CE; Wagh MS
    Pancreas; 2014 Aug; 43(6):922-6. PubMed ID: 24979616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of endoscopic ultrasound and endoscopic ultrasound-guided fine-needle aspiration in diagnosing metastasis to the pancreas: a tertiary center experience.
    Hijioka S; Matsuo K; Mizuno N; Hara K; Mekky MA; Vikram B; Hosoda W; Yatabe Y; Shimizu Y; Kondo S; Tajika M; Niwa Y; Tamada K; Yamao K
    Pancreatology; 2011; 11(4):390-8. PubMed ID: 21894056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of pancreatic juice cytology and/or endoscopic ultrasound-guided fine-needle aspiration biopsy for pancreatic tumor.
    Matsumoto K; Takeda Y; Harada K; Horie Y; Yashima K; Murawaki Y
    J Gastroenterol Hepatol; 2014 Jan; 29(1):223-7. PubMed ID: 23869654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Performance of K-ras mutation analysis plus endoscopic ultrasound-guided fine-needle aspiration for differentiating diagnosis of pancreatic solid mass: a meta-analysis.
    Xu Y; Hu D; Zhu Q; Sun Y
    Chin Med J (Engl); 2014; 127(18):3296-301. PubMed ID: 25266530
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Repeated endoscopic ultrasound guided fine needle aspiration (EUS-FNA) improved diagnostic yield of inconclusive initial cytology for suspected pancreatic cancer and unknown intra-abdominal lymphadenopathy.
    Prachayakul V; Sriprayoon T; Asawakul P; Pongprasobchai S; Pausawasdi N; Kachintorn U
    J Med Assoc Thai; 2012 Feb; 95 Suppl 2():S68-74. PubMed ID: 22574532
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of repeated endoscopic ultrasound-guided fine needle aspiration in small solid pancreatic masses with previous indeterminate and negative cytological findings.
    Tadic M; Kujundzic M; Stoos-Veic T; Kaic G; Vukelic-Markovic M
    Dig Dis; 2008; 26(4):377-82. PubMed ID: 19188731
    [TBL] [Abstract][Full Text] [Related]  

  • 56. KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-control.
    Le Calvez-Kelm F; Foll M; Wozniak MB; Delhomme TM; Durand G; Chopard P; Pertesi M; Fabianova E; Adamcakova Z; Holcatova I; Foretova L; Janout V; Vallee MP; Rinaldi S; Brennan P; McKay JD; Byrnes GB; Scelo G
    Oncotarget; 2016 Nov; 7(48):78827-78840. PubMed ID: 27705932
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Digital PCR-based plasma cell-free DNA mutation analysis for early-stage pancreatic tumor diagnosis and surveillance.
    Okada T; Mizukami Y; Ono Y; Sato H; Hayashi A; Kawabata H; Koizumi K; Masuda S; Teshima S; Takahashi K; Katanuma A; Omori Y; Iwano H; Yamada M; Yokochi T; Asahara S; Kawakubo K; Kuwatani M; Sakamoto N; Enomoto K; Goto T; Sasajima J; Fujiya M; Ueda J; Matsumoto S; Taniue K; Sugitani A; Karasaki H; Okumura T
    J Gastroenterol; 2020 Dec; 55(12):1183-1193. PubMed ID: 32939577
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimizing the multimodal approach to pancreatic cyst fluid diagnosis: developing a volume-based triage protocol.
    Chai SM; Herba K; Kumarasinghe MP; de Boer WB; Amanuel B; Grieu-Iacopetta F; Lim EM; Segarajasingam D; Yusoff I; Choo C; Frost F
    Cancer Cytopathol; 2013 Feb; 121(2):86-100. PubMed ID: 22961878
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The value of mutational profiling of the cytocentrifugation supernatant fluid from fine-needle aspiration of pancreatic solid mass lesions.
    Deftereos G; Finkelstein SD; Jackson SA; Ellsworth EM; Krishnamurti U; Liu Y; Silverman JF; Binkert CR; Ujevich BA; Mohanty A
    Mod Pathol; 2014 Apr; 27(4):594-601. PubMed ID: 24051700
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low frequency of KRAS mutation in pancreatic ductal adenocarcinomas in Korean patients and its prognostic value.
    Kwon MJ; Jeon JY; Park HR; Nam ES; Cho SJ; Shin HS; Kwon JH; Kim JS; Han B; Kim DH; Choi YL
    Pancreas; 2015 Apr; 44(3):484-92. PubMed ID: 25513781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.